References
- Ahiwale, R.J., Chellampillai, B., and Pawar, A.P., 2020. Investigation of 1, 2-Dimyristoyl-sn-glycero-3-phosphoglycerol-sodium (DMPG-Na) lipid with various metal cations in nanocochleate preformulation: Application for Andrographolide oral delivery in cancer therapy. AAPS pharmscitech, 21 (7), 279.
- Ahiwale, R.J., Chellampillai, B., and Pawar, A.P., 2022. Investigation of novel sorafenib tosylate loaded biomaterial based nano-cochleates dispersion system for treatment of hepatocellular carcinoma. Journal of dispersion science and technology, 43 (10), 1568–1586.
- Aigner, M., and Lass-Flörl, C., 2020. Encochleated amphotericin B: Is the oral availability of amphotericin B finally reached? Journal of fungi, 6 (2), 66.
- Asprea, M., et al., 2019. Stable, monodisperse, and highly cell-permeating nanocochleates from natural soy lecithin liposomes. Pharmaceutics, 11 (1), 34.
- Bacalum, M., Zorilă, B., and Radu, M., 2013. Fluorescence spectra decomposition by asymmetric functions: Laurdan spectrum revisited. Analytical biochemistry, 440 (2), 123–129.
- Boeckxstaens, G., 2009. Emerging drugs for gastroesophageal reflux disease. Expert opinion on emerging drugs, 14 (3), 481–491.
- Bothiraja, C., et al., 2014. Fisetin-loaded nanocochleates: Formulation, characterisation, in vitro anticancer testing, bioavailability and biodistribution study. Expert opinion on drug delivery, 11 (1), 17–29.
- Briuglia, M.L., et al., 2015. Influence of cholesterol on liposome stability and on in vitro drug release. Drug delivery and translational research, 5 (3), 231–242.
- Calvo, A., et al., 2020. Berberine-loaded liposomes for the treatment of Leishmania infantum-infected BALB/c mice. Pharmaceutics, 12 (9), 858.
- Çoban, Ö., and Değim, Z., 2018. Development of nanocochleates containing erlotinib HCl and dexketoprofen trometamol and evaluation of in vitro characteristic properties. Turkish journal of pharmaceutical sciences, 15 (1), 16–21.
- Çoban, Ö., et al., 2019. Efficacy of targeted liposomes and nanocochleates containing imatinib plus dexketoprofen against fibrosarcoma. Drug development research, 80 (5), 556–565.
- Garcı́a-Fuentes, M., Torres, D., and Alonso, M.J., 2003. Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Colloids and surfaces B: biointerfaces, 27 ((2-3), 159–168.
- Goo, Y.T., et al., 2021a. Development of a solid supersaturable micelle of revaprazan for improved dissolution and oral bioavailability using Box-Behnken design. International journal of nanomedicine, 16, 1245–1259.
- Goo, Y.T., et al., 2021b. Cochleate formulation enhances the stability of lansoprazole in acidic condition. Bulletin of the Korean chemical society, 42 (10), 1281–1284.
- Goo, Y.T., et al., 2022a. Enhanced dissolution and bioavailability of revaprazan using self-nanoemulsifying drug delivery system. Pharmaceutical development and technology, 27 (4), 414–424.
- Goo, Y.T., et al., 2022b. Enhanced oral absorption of insulin: hydrophobic ion pairing and a self-microemulsifying drug delivery system using a D-optimal mixture design. Drug delivery, 29 (1), 2831–2845.
- Guo, M., et al., 2019. Impacts of particle shapes on the oral delivery of drug nanocrystals: mucus permeation, transepithelial transport and bioavailability. Journal of controlled release: official journal of the controlled release society, 307, 64–75.
- Hallan, S.S., et al., 2020. Design of Nanosystems for the Delivery of Quorum Sensing Inhibitors: A Preliminary Study. Molecules, 25 (23), 5655.
- Hamada, N., and Longo, M.L., 2022. Characterization of phase separation phenomena in hybrid lipid/block copolymer/cholesterol bilayers using laurdan fluorescence with log-normal multipeak analysis. Biochimica et biophysica acta. biomembranes, 1864 (5), 183887.
- Han, K.S., et al., 1998. Pharmacokinetics of a new reversible proton pump inhibitor, YH1885, after intravenous and oral administrations to rats and dogs: Hepatic first‐pass effect in rats. Biopharmaceutics & drug disposition, 19 (8), 493–500.
- He, H., et al., 2019. Adapting liposomes for oral drug delivery. Acta pharmaceutica sinica. B, 9 (1), 36–48.
- Inatomi, N., et al., 2016. Potassium-competitive acid blockers: Advanced therapeutic option for acid-related diseases. Pharmacology & therapeutics, 168, 12–22.
- Judeh, Z., and Shuddhodana, 2021. Insights into the mechanism of formation of non-conventional cochleates and its impact on their functional properties. Journal of molecular liquids, 335, 116249.
- Khair, R., Shende, P., and Kulkarni, Y.A., 2020. Nanostructured polymer-based cochleates for effective transportation of insulin. Journal of molecular liquids, 311, 113352.
- Kim, J.S., et al., 2018. Novel revaprazan-loaded gelatin microsphere with enhanced drug solubility and oral bioavailability. Journal of microencapsulation, 35 (5), 421–427.
- Li, Y., and McClements, D.J., 2010. New mathematical model for interpreting pH-stat digestion profiles: Impact of lipid droplet characteristics on in vitro digestibility. Journal of agricultural and food chemistry, 58 (13), 8085–8092.
- Li, Z., et al., 2017. Development of Liposome containing sodium deoxycholate to enhance oral bioavailability of itraconazole. Asian journal of pharmaceutical sciences, 12 (2), 157–164.
- Lipa-Castro, A., et al., 2021. Cochleate formulations of Amphotericin b designed for oral administration using a naturally occurring phospholipid. International journal of pharmaceutics, 603, 120688.
- Lipa-Castro, A., Legrand, F.X., and Barratt, G., 2021. Cochleate drug delivery systems: An approach to their characterization. International journal of pharmaceutics, 610, 121225.
- Liu, M., Zhong, X., and Yang, Z., 2017. Chitosan functionalized nanocochleates for enhanced oral absorption of cyclosporine A. Scientific reports, 7 (1), 10.
- Liu, W., et al., 2019. Structural stability of liposome-stabilized oil-in-water pickering emulsions and their fate during in vitro digestion. Food & function, 10 (11), 7262–7274.
- Livne, L., et al., 2010. OAK‐based cochleates as a novel approach to overcome multidrug resistance in bacteria. FASEB journal: official publication of the federation of american societies for experimental biology, 24 (12), 5092–5101.
- Miclea, R.D., et al., 2007. Development and characterization of lipidic cochleate containing recombinant factor VIII. Biochimica et biophysica acta, 1768 (11), 2890–2898.
- Mura, P., et al., 2005. Optimization of glibenclamide tablet composition through the combined use of differential scanning calorimetry and D-optimal mixture experimental design. Journal of Pharmaceutical and biomedical analysis, 37 (1), 65–71.
- Nagarsekar, K., et al., 2016. Understanding cochleate formation: insights into structural development. Soft matter, 12 (16), 3797–3809.
- Park, J.H., et al., 2018. Comparison of a revaprazan-loaded solid dispersion, solid SNEDDS and inclusion compound: Physicochemical characterisation and pharmacokinetics. Colloids and surfaces B, Biointerfaces, 162, 420–426.
- Park, J.H., et al., 2019. Revaprazan-loaded surface-modified solid dispersion: physicochemical characterization and in vivo evaluation. Pharmaceutical development and technology, 24 (6), 788–793.
- Pawar, A., et al., 2015. An insight into cochleates, a potential drug delivery system. RSC advances, 5 (99), 81188–81202.
- Ramani, K., and Balasubramanian, S.V., 2003. Fluorescence properties of Laurdan in cochleate phases. Biochimica et biophysica acta, 1618 (1), 67–78.
- Rao, R., Squillante, E., III,., and Kim, K.H., 2007. Lipid-based cochleates: A promising formulation platform for oral and parenteral delivery of therapeutic agents. Critical reviews in therapeutic drug carrier systems, 24 (1), 41–61.
- Righeschi, C., et al., 2014. Strategy to provide a useful solution to effective delivery of dihydroartemisinin: Development, characterization and in vitro studies of liposomal formulations. Colloids and surfaces B, biointerfaces, 116, 121–127.
- Shahid, S.K., 2014. Novel anti-Helicobacter pylori therapies. Pharmaceutical patent analyst, 3 (4), 411–427.
- Shanmugam, T., et al., 2020. Enhanced absorption, and efficacy of oral self-assembled paclitaxel nanocochleates in multi-drug resistant colon cancer. International journal of pharmaceutics, 586, 119482.
- Shende, P., Khair, R., and Gaud, R.S., 2019. Nanostructured cochleates: A multi-layered platform for cellular transportation of therapeutics. Drug development and industrial pharmacy, 45 (6), 869–881.
- Suzuki, H., 2018. New pharmacological treatments for gastroesophageal reflux: Potassium-competitive acid blockers and bile acid sequestrants. NeuroGastroLATAM reviews, 2 (1), 18–27.
- Son, H.Y., et al., 2018. Optimization of self-microemulsifying drug delivery system for phospholipid complex of telmisartan using D-optimal mixture design. PLoS one, 13 (12), e0208339.
- Syed, U.M., et al., 2008. Cochleates bridged by drug molecules. International journal of pharmaceutics, 363 (1-2), 118–125.
- Szilágyi, A., Selstam, E., and Akerlund, H.-E., 2008. Laurdan fluorescence spectroscopy in the thylakoid bilayer: the effect of violaxanthin to zeaxanthin conversion on the galactolipid dominated lipid environment. Biochimica et biophysica acta, 1778 (1), 348–355.
- Tan, C., et al., 2014. Modulation of the carotenoid bioaccessibility through liposomal encapsulation. Colloids and surfaces B, biointerfaces, 123, 692–700.
- Tang, J., Bai, Y., and Chen, X., 2021. An investigation of inorganic fillers on rheological properties and tensile strength of epoxy repair coating using mixture design method. Construction and building materials, 307, 124866.
- Vakil, N., 2004. New pharmacological agents for the treatment of gastro‐oesophageal reflux disease. Alimentary pharmacology & therapeutics, 19 (10), 1041–1049.
- Vanić, Ž., et al., 2013. Characterization of various deformable liposomes with metronidazole. Drug Development and industrial pharmacy, 39 (3), 481–488.
- Zhong, X., Chen, B., and Yang, Z., 2018. Nanocochleates as the potential delivery systems for oral antitumor of hydroxycamptothecin. Journal of biomedical nanotechnology, 14 (7), 1339–1346.